Navigation Links
Get the Leading Fucoidan Supplement on the go With LIMU ORIGINAL(TM) SHOT

LAKE MARY, Fla., June 1 /PRNewswire/ -- The leading daily Fucoidan supplement, LIMU ORIGINAL™, is now available in a convenient two-ounce pouch as the LIMU ORIGINAL™ SHOT.  LIMU, the recognized marketplace leader of Fucoidan-based products, launched the new packaging as a part of their brand transformation initiatives.  The company has introduced several Fucoidan products into the marketplace, focusing on the marine bioactive's antioxidant, cardiovascular, energy and weight management benefits.  

(Logo: )

"Fucoidan is an incredible supernutrient with proven science that offers wholesome, complete nutrition in today's fast-paced world," said Gary J. Raser, LIMU President and CEO.  "It is our company's privilege and mission to share the rich benefits of Fucoidan, and the LIMU ORIGINAL™ SHOT pouch delivery system gives consumers a chance to enjoy the potent power of LIMU ORIGINAL™ wherever they are, every day."

According to the company, the marine bioactive Fucoidan continues to garner attention as it is used in more and more consumer health products worldwide.  LIMU developed a proprietary extract with scientists familiar with the brown seaweed, limu moui, where Fucoidan is in high concentration, along with 77 additional nutritional elements.  Ongoing studies continue to strengthen Fucoidan's position as an emerging ingredient for a range of health products within the nutritionals industry.

"Our new LIMU ORIGINAL™ SHOT pouches are yet another way for our company to educate the world about Fucoidan's powerful benefits, and we continue to bring the latest developments to the marketplace," said Raser.  The company employs a direct sales business model, allowing all consumers to make additional income selling Fucoidan-based products while efficiently increasing market penetration.  LIMU will work to advance Fucoidan information in upcoming marketing campaigns.  

About LIMU™

LIMU is an established global nutritional company solely focused on marketing the rich health benefits of marine bioactive, Fucoidan.  Employing a direct sales business model, LIMU continues to expand its network of Members across the globe, with tens of millions of dollars in commissions paid. Based in Florida, LIMU is an industry leading home-based business opportunity, helping people to enjoy a higher quality of life. For more information on LIMU and its exclusive Fucoidan product formulas, please visit

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
3. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
4. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
5. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
6. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
7. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
8. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
9. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
10. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
Breaking Medicine News(10 mins):